Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Powerful red chemotherapy for breast cancer, lymphoma and sarcoma. | Chemotherapy that also treats severe autoimmune disease. |
| Body system | Cancer | Cancer |
| Drug class | Anthracyclines | Alkylating agents |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Breast cancer, Lymphomas, Leukaemias, Sarcomas, Many childhood cancers | Lymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplants |
| How it works | Damages cancer cell DNA so they can't divide. | Damages DNA so dividing cells die. |
| Starts working | — | — |
| Half-life | — | — |
| Typical adult dose | Dose by body surface area per cycle; lifetime maximum around 450–550 mg/m². | Varies widely by condition and regimen. |
| Forms | IV infusion, Liposomal infusion | IV infusion, Tablet |
| Common side effects | Hair loss, Nausea, Mouth sores, Red urine (1–2 days), Low blood counts | Nausea, Hair loss, Low blood counts |
| Serious side effects | Heart damage (dose-related, can appear years later), Severe tissue damage if it leaks from the vein, Secondary leukaemia (rare) | Bleeding from the bladder, Infertility, Secondary cancers, Infections |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Usually avoidedAvoided in the first trimester; sometimes given later under specialists. | Usually avoidedCauses birth defects. |
| Breastfeeding | — | — |
| In use since | 1974 | 1959 |
| Brand names | United States: Adriamycin, DoxilUnited Kingdom: CaelyxIndia: Adriamycin, Lipodox | United States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, Cyclomide |
| Legal status | — | — |
| ATC code | L01DB01 | L01AA01 |
Taken together
- ModerateDoxorubicin + Cyclophosphamide: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.